Newswise — Sbarro Health Research Organization (http://www.shro.org), a non-profit group that funds innovative basic research designed to diagnose and treat a variety of diseases, including cancer and cardiovascular disease, will join Roche Diagnostics in an on-site agreement that will provide supplies to researchers at SHRO labs.
Antonio Giordano, M.D., PhD., founder and president of SHRO and director of the Sbarro Institute for Cancer Research and Molecular Medicine and the Center for Biotechnology in Temple's College of Science and Technology, announced the agreement in Philadelphia.
"With this agreement, the first of its kind for SHRO, we will be able to strengthen an already strong research program, to add to our existing technologies, and to realize even more benefits from our research dollars," says Giordano. "In a world where money for basic research is so vital, selecting Roche as a premier supplier has given us an opportunity to advance work that will lead to important cures and diagnostic tools for a variety of different diseases."
About Sbarro Health Research OrganizationSHRO (http://www.shro.org) SHRO funds the Sbarro Institute for Cancer Research and Molecular Therapeutics located at Temple University in Philadelphia, PA as well as a lab in Siena, Italy located at the University of Siena.
About Roche and the Roche Diagnostics Division Headquartered in Basel, Switzerland, Roche is one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As a supplier of innovative products and services for the early detection, prevention, diagnosis and treatment of disease, the Group contributes on a broad range of fronts to improving people's health and quality of life. Roche is a world leader in diagnostics, the leading supplier of medicines for cancer and transplantation and a market leader in virology. Roche employs roughly 70,000 people in 150 countries and has R&D agreements and strategic alliances with numerous partners, including majority ownership interests in Genentech and Chugai. Roche's Diagnostics Division offers a uniquely broad product portfolio and supplies a wide array of innovative testing products and services to researchers, physicians, patients, hospitals and laboratories world-wide. Roche Diagnostics' North American headquarters is located in Indianapolis, Ind. (http://www.roche-diagnostics.us). Additionally, you can access more information about Roche at http://www.roche.us.
RSS